This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.1.0: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v3.5.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "ValueSet",
"id" : "valueset-cyclosporine-exclude",
"text" : {
"status" : "generated",
"div" : "<div xmlns="http://www.w3.org/1999/xhtml"><h2>Exclude cyclosporine Medications Value Set</h2><div><p>ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.</p>
</div><p><b>Copyright Statement:</b> Attribution CC BY</p><p>This value set includes codes from the following code systems:</p><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1093178</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]</td><td/></tr><tr><td>402092</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]</td><td/></tr><tr><td>1093177</td><td>Cyclosporine Ophthalmic Ointment [Optimmune]</td><td/></tr><tr><td>402330</td><td>Cyclosporine Ophthalmic Suspension [Restasis]</td><td/></tr><tr><td>1093174</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment</td><td/></tr><tr><td>351291</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension</td><td/></tr><tr><td>1093173</td><td>Cyclosporine Ophthalmic Ointment</td><td/></tr><tr><td>378766</td><td>Cyclosporine Ophthalmic Suspension</td><td/></tr><tr><td>1156187</td><td>Cyclosporine Ophthalmic Product</td><td/></tr><tr><td>1182342</td><td>Optimmune Ophthalmic Product</td><td/></tr><tr><td>1182527</td><td>Restasis Ophthalmic Product</td><td/></tr></table></li></ul></div>"
},
"url" : "http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude",
"version" : "0.1.0",
"name" : "valueset-cyclosporine-exclude",
"title" : "Exclude cyclosporine Medications Value Set",
"status" : "draft",
"date" : "2018-07-02",
"publisher" : "PDDI CDS",
"contact" : [
{
"name" : "Richard Boyce boycerd@upmc.edu"
}
],
"description" : "ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "International"
}
]
}
],
"purpose" : "To refine valueset for Digoxin + Cyclosporine PDDI-CDS",
"copyright" : "Attribution CC BY",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "02-Jul-2018",
"concept" : [
{
"code" : "1093178",
"display" : "Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]"
},
{
"code" : "402092",
"display" : "Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]"
},
{
"code" : "1093177",
"display" : "Cyclosporine Ophthalmic Ointment [Optimmune]"
},
{
"code" : "402330",
"display" : "Cyclosporine Ophthalmic Suspension [Restasis]"
},
{
"code" : "1093174",
"display" : "Cyclosporine 0.002 MG/MG Ophthalmic Ointment"
},
{
"code" : "351291",
"display" : "Cyclosporine 0.5 MG/ML Ophthalmic Suspension"
},
{
"code" : "1093173",
"display" : "Cyclosporine Ophthalmic Ointment"
},
{
"code" : "378766",
"display" : "Cyclosporine Ophthalmic Suspension"
},
{
"code" : "1156187",
"display" : "Cyclosporine Ophthalmic Product"
},
{
"code" : "1182342",
"display" : "Optimmune Ophthalmic Product"
},
{
"code" : "1182527",
"display" : "Restasis Ophthalmic Product"
}
]
}
]
}
}